486 filings
20-F/A
2023 FY
CYTO
Altamira Therapeutics Ltd
22 Apr 24
Annual report (foreign) (amended)
4:31pm
EFFECT
CYTO
Altamira Therapeutics Ltd
18 Apr 24
Notice of effectiveness
12:15am
424B4
CYTO
Altamira Therapeutics Ltd
17 Apr 24
Prospectus supplement with pricing info
4:20pm
6-K
CYTO
Altamira Therapeutics Ltd
16 Apr 24
Notice of the Annual General Meeting of Shareholders
5:00pm
6-K
CYTO
Altamira Therapeutics Ltd
10 Apr 24
Altamira Therapeutics Provides Business Update, Reports Full Year 2023 Financial Results
8:30am
S-8
gxvdrem4juzevfs
10 Apr 24
Registration of securities for employees
8:15am
F-1
zaukfuz6v nkdzdto5
10 Apr 24
Registration statement (foreign)
8:15am
SC 13D/A
3z0yo1
13 Mar 24
Altamira Therapeutics / Meyer Thomas ownership change
11:03am
424B4
65vx36fguoqby7i4b4n
22 Jan 24
Prospectus supplement with pricing info
5:02pm
EFFECT
rs0dw0 l00l0
22 Jan 24
Notice of effectiveness
12:15am
6-K
gobie3wuvx0b8 5geaj2
19 Jan 24
Report of Foreign Private Issuer
4:45pm
424B5
oumnjo1 ipdq
19 Jan 24
Prospectus supplement for primary offering
4:40pm
6-K
5vxp024puisck7c4l
19 Jan 24
Report of Foreign Private Issuer
4:30pm
CORRESP
fa9kytu
17 Jan 24
Correspondence with SEC
12:00am
UPLOAD
ty9avkhoe6oy 5q4
16 Jan 24
Letter from SEC
12:00am
F-3
sazm9d 5il577v
8 Jan 24
Shelf registration (foreign)
5:02pm
6-K
q068u3i g98pf
11 Dec 23
Altamira Therapeutics Provides Investor and Business Update
8:01am
6-K
x1x1mfcxdtkicn
11 Dec 23
Report of Foreign Private Issuer
8:00am
6-K
rlr 510gog8gkje2vx67
8 Dec 23
Report of Foreign Private Issuer
9:00am